Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by SouthernTierTomon May 02, 2022 11:22pm
138 Views
Post# 34649973

RE:"Market"? No invester shows in the last 2 years?

RE:"Market"? No invester shows in the last 2 years?CONFUSED or impaired? ...

Actually chum...I'm comparing TLT to T.BLU ..a phase 2 chronic cough player valued over 20 TIMES the value of TLT..

You might want to find out why we aren't "sharing our story" ..DO IT QUICK before the next raise..

JMHO..

Maybe it is really good at the end of the day and people want as much as possible at 
the best possible price?

The science does indeed appear worthy of attention, but without a marketing strategy buying pressure will evade us

Feels like another UHN gem... Spectral Medical has 4 FDA approvals and a current phase 3B FDA confirmatory trial with a 2.10 cad SP target and an OTC listing here in the US with NO newsflow to America in the last 66 months... more UHN rooted science and heavy insider rooted ownership
Is this the same kind of story?

Time to get real here and cut the story telling bullbored bull

24 cents for a phase 2B FDA fast track for cancer?

yeah... keep chatting up that covey vax ; - )



Something doesnt add up here... a FDA fast track and a 50 mill market csp.. phase 2 Bellus worth 1.2 Billion for chronic cough remedy?  Hmmm??
<< Previous
Bullboard Posts
Next >>